HUP0200376A3 - Thiaoloindolinone compounds, process for their preparation and pharmaceutical composions containing them and their use - Google Patents

Thiaoloindolinone compounds, process for their preparation and pharmaceutical composions containing them and their use

Info

Publication number
HUP0200376A3
HUP0200376A3 HU0200376A HUP0200376A HUP0200376A3 HU P0200376 A3 HUP0200376 A3 HU P0200376A3 HU 0200376 A HU0200376 A HU 0200376A HU P0200376 A HUP0200376 A HU P0200376A HU P0200376 A3 HUP0200376 A3 HU P0200376A3
Authority
HU
Hungary
Prior art keywords
thiaoloindolinone
composions
pharmaceutical
compounds
preparation
Prior art date
Application number
HU0200376A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of HUP0200376A2 publication Critical patent/HUP0200376A2/hu
Publication of HUP0200376A3 publication Critical patent/HUP0200376A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
HU0200376A 1999-03-04 2000-03-01 Thiaoloindolinone compounds, process for their preparation and pharmaceutical composions containing them and their use HUP0200376A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9904930.6A GB9904930D0 (en) 1999-03-04 1999-03-04 Thiazoloindolinone compounds

Publications (2)

Publication Number Publication Date
HUP0200376A2 HUP0200376A2 (en) 2002-06-29
HUP0200376A3 true HUP0200376A3 (en) 2003-07-28

Family

ID=10848912

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200376A HUP0200376A3 (en) 1999-03-04 2000-03-01 Thiaoloindolinone compounds, process for their preparation and pharmaceutical composions containing them and their use

Country Status (18)

Country Link
EP (1) EP1159280A2 (fr)
JP (1) JP2003532620A (fr)
KR (1) KR20020005606A (fr)
CN (1) CN1355807A (fr)
AU (1) AU3611000A (fr)
BR (1) BR0008677A (fr)
CA (1) CA2361580A1 (fr)
CZ (1) CZ20013187A3 (fr)
GB (1) GB9904930D0 (fr)
HK (1) HK1041692A1 (fr)
HU (1) HUP0200376A3 (fr)
IL (1) IL144808A0 (fr)
MX (1) MXPA01008910A (fr)
NO (1) NO20014262L (fr)
PL (1) PL351476A1 (fr)
TR (1) TR200102557T2 (fr)
WO (1) WO2000052013A2 (fr)
ZA (1) ZA200106826B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
US7439252B2 (en) * 2004-12-01 2008-10-21 TEVA Gyógyszergyár Zártkörúen Müködö Részvénytársaság Ascomycin crystalline forms and preparation thereof
UA103319C2 (en) * 2008-05-06 2013-10-10 Глаксосмитклайн Ллк Thiazole- and oxazole-benzene sulfonamide compounds
JP4761000B1 (ja) * 2010-11-08 2011-08-31 小野薬品工業株式会社 手足症候群の予防および／または治療剤
ES2604705T3 (es) 2010-03-31 2017-03-08 Ono Pharmaceutical Co., Ltd. Agente preventivo y/o remedio para el síndrome mano-pie
JP2021506958A (ja) 2017-12-13 2021-02-22 オンクォリティ ファーマシューティカルズ チャイナ エルティーディーＯｎｑｕａｌｉｔｙ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｈｉｎａ Ｌｔｄ． Ｅｇｆｒ阻害に関連する疾患を予防又は治療する方法
EP3782618A4 (fr) 2018-04-16 2022-01-26 OnQuality Pharmaceuticals China Ltd. Méthode pour prévenir ou traiter les effets secondaires d'une cancérothérapie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2289102A1 (fr) * 1997-05-07 1998-11-12 Sugen, Inc. Derives de 2-indolinone utilises en tant que modulateurs de l'activite de la proteine kinase
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives

Also Published As

Publication number Publication date
NO20014262D0 (no) 2001-09-03
JP2003532620A (ja) 2003-11-05
CN1355807A (zh) 2002-06-26
NO20014262L (no) 2001-10-30
MXPA01008910A (es) 2002-03-27
HUP0200376A2 (en) 2002-06-29
TR200102557T2 (tr) 2007-01-22
HK1041692A1 (zh) 2002-07-19
WO2000052013A2 (fr) 2000-09-08
ZA200106826B (en) 2003-02-25
BR0008677A (pt) 2002-01-08
GB9904930D0 (en) 1999-04-28
CA2361580A1 (fr) 2000-09-08
IL144808A0 (en) 2002-06-30
EP1159280A2 (fr) 2001-12-05
KR20020005606A (ko) 2002-01-17
PL351476A1 (en) 2003-04-22
CZ20013187A3 (cs) 2002-02-13
WO2000052013A3 (fr) 2000-12-28
AU3611000A (en) 2000-09-21

Similar Documents

Publication Publication Date Title
HUP0300618A3 (en) Adamantana derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0203548A3 (en) New spirooxindole derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0204245A3 (en) Novel n-azabicyclo-amide derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203136A3 (en) Piperazine compounds, process for their preparation, pharmaceutical compositions containing them and their use
HUP0200396A3 (en) Gluckokinase activators, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203294A3 (en) Benzodiazepine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203766A3 (en) 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof and pharmaceutical compositions containing them
HUP0203316A3 (en) Amino-triazolopyridine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0203902A3 (en) Substituted oxazolidinones, process for their preparation and pharmaceutical compositions containing them and their use
HUP0201376A2 (en) Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds
HUP0300616A3 (en) Adamantane derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0203183A3 (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use
HUP0201122A2 (en) Pyrimidinone compounds, process for their preparation and pharmaceutical compositions containing them
HUP0203052A3 (en) Bicyclic imidazo-3-yl-amine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0002843A3 (en) New betha-carboline compounds, a process for their preparation and pharmaceutical compositions containing them
HUP0105108A3 (en) Amide compounds, process for their preparation and pharmaceutical compositions containing them
HUP0201516A2 (en) 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
IL148870A (en) 2'-substituted 1,1'-biphenyl - 2 - carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
HUP0102512A3 (en) Bridged indenopyrrolocarbazoles, process for their preparation, pharmaceutical compositions containing them and their use
HUP0201753A2 (en) Pyridopyranoazepine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0202075A3 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0201206A3 (en) Antibacterial compounds, process for their preparation and pharmaceutical compositions containing them
HUP0201402A3 (en) Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them
HUP0203184A3 (en) Isoxazolecarboxamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0203597A3 (en) Pharmaceutical compositions containing zolmitriptan, process for their preparation and their use